Insider · CIK 0001117167
Charles J Casamento
director
Files at GTBP (GT Biopharma, Inc.), RLMD (RELMADA THERAPEUTICS, INC.), ETON (Eton Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +12,196 | $0.00 | $0 | 295,171 | Jan 14, 2026 |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +7,757 | $0.00 | $0 | 302,928 | Jan 14, 2026 |
| Dec 12, 2025 | RLMD RELMADA THERAPEUTICS, INC. | AGrant or award Stock Appreciation Rightsderivative | +164,000 | $0.00 | $0 | 164,000 | Dec 16, 2025 |
| Sep 4, 2025 | GTBP GT Biopharma, Inc. | AGrant or award Option to purchase Common Stockderivative | +62,500 | $0.00 | $0 | 62,500 | Sep 8, 2025 |
| Jun 26, 2025 | RLMD RELMADA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jun 30, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2025 |
| Oct 22, 2024 | RLMD RELMADA THERAPEUTICS, INC. | GGift Common Stock | -13,000 | $0.00 | $0 | 0 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.